Develop ultramodern molecular biology laboratory for ovarian cancer patients
Pre-operative molecular biological and dynamic MR report at endometrial cancer
Oncolex: Oncolex is a reference work for oncologic health personnel where you will find background information and updated procedures in diagnostics, cancer treatment and results. Web site www.oncolex.no will provide information related to the treatment and results of cervix, endometrium, ovarium and vulva cancer
Cytostatica manual: A comprehensive booklet with practical guidelines to all chemocourses given to gynecologic oncologic patients in Norway.
We cooperate with several research groups at the Norwegian Radium Hospital, where we compare inheritable ovary cancer with knowledge from sporadic cancer and other genetic defects. Our aim is to understand how cancer develops, arises and evolve, and why some people develop resistans against treatment. Our hope is to find new and improved treatment forms for each woman.
Vergote I, Coens C, Nankivell M, Kristensen GB, Parmar MKB, Ehlen T, Jayson GC, Johnson N, Swart AM, Verheijen R, McCluggage WG, Perren T, Panici PB, Kenter G, Casado A, Mendiola C, Stuart G, Reed NS, Kehoe S, EORTC, MRC CHORUS study investigators(2018) Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials Lancet Oncol(in press) DOI 10.1016/S1470-2045(18)30566-7, PubMed 30413383
Lindemann K, Beale PJ, Rossi E, Goh JC, Vaughan MM, Tenney ME, Martyn JK, Sommeijer D, Iglesias JL, Kremmidiotis G, Simpson J, Doolin E, Lavranos TC, Leske A, Veillard AS, Espinoza D, Stockler MR, Rischin D, For ANZGOG and HCRN Collaborative Groups(2018) Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103) Cancer Chemother Pharmacol(in press) DOI 10.1007/s00280-018-3706-5, PubMed 30368585
Smogeli E, Cvancarova M, Wang Y, Davidson B, Kristensen G, Lindemann K(2018) Clinical Outcome of Patients With High-Risk Endometrial Carcinoma After Treatment With Chemotherapy Only Int J Gynecol Cancer, 28(9), 1789-1795 DOI 10.1097/IGC.0000000000001356, PubMed 30365455